Shares of #Moderna and #Merck soared on Wednesday morning after a study showed that a vaccine they produced had promising results when it comes to fighting skin cancer. A late-stage trial showed that the mRNA vaccine helped reduce the recurrence of #melanoma. #SamFazeli of youtu.be/gkuTIhvRrck

#BloombergIntelligence's #SamFazeli discusses #AbbVie's $10.9 billion acquisition of #ApogeeTherapeutics The deal enhances AbbVie presence in dermatology by adding treatments for atopic dermatitis commonly known as eczema, to its portfolio He speaks on
#BloombergOpenInterest." youtu.be/3IirXi8_wtE